Markets
PMD

Health Care Sector Update for 01/31/2017: PMD,AEZS,TENX

Top Health Care Stocks

JNJ -0.07%

PFE +1.14%

MRK +1.77%

ABT +0.89%

AMGN +1.36%

Health care stocks were set to close mostly higher today after the White House today promised less regulation and more competition for drugmakers at a meeting today with industry executives. The NYSE Health Care Index added 1.0% in value today while shares of health care companies in the S&P 500 stretched out to a 1.4% gain as a group.

In company news, Psychemedics ( PMD ) lost almost 30% in value Tuesday after attorneys representing a U.S. rival said the forensic hair drug testing company may be on the hook for a seven-figure fine after Psychemedics's Brazilian partner was cited for anticompetitive practices aiming to keep the other company out of the South American nation.

The 23rd Civil Court of Brasilia Jan. 20 ordered Psychemedics Brazil to indemnify Omega Laboratories Inc USA for lost profits and other damages after reviewing and upholding the termination of an exclusivity agreement between the companies, according to the Figueira Hong law firm, which represented Omega Labs in the Brazilian court. The attorneys did not specify how much Psychemedics owes but today asserted it could be in the "millions of dollars."

The ruling also bars Psychemedics Brazil from using the Omega name in any form, including on its internet domain, or risk a 5,000-real daily fine. There was no apparent comment by Psychemedics on Tuesday on the attorney assertions.

PMD shares were down over 28% at $15.85 apiece, earlier dropping to a session low of $13.81 a share.

In other sector news,

(+) AEZS, (+23.5%) Expects to present positive trial results in April after today saying it has completed Phase III testing of ZoptEC drug candidate in women with certain forms of endometrial cancer.

(-) TENX, Levosimendan drug candidate fails to produce statistically significant reduction in mortality or dialysis use after 30 days in patients at risk of low cardiac output syndrome during cardiac surgery.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PMD AEZS TENX

Other Topics

US Markets

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More